Tag Archives: Gilead Sciences

Gilead seeks FDA approval for COVID-19 drug inhibitor

Gilead Sciences on Monday applied for approval from the U.S. Food and Drug Administration for its COVID-19 treatment, remdesivir. The biotech company also said the antiviral drug will go by the Veklury brand name in the US “Submitting today is a major milestone as we continue to work with the …

Read More »

FDA approves Gilead’s second CAR-T cancer therapy

The Food and Drug Administration has approved an advanced treatment for mantle cell lymphoma, a rare type of cancer that affects white blood cells. The one-time therapy, done by Gilead Sciences, is marked as Tecartus. Because it is important: This is the third federal approval for a CAR-T therapy, a …

Read More »